Asgary et al., 2008
|
Opium addicted |
Case-control |
n = 720 smoker men (360 opium addict, 360 non-addict) |
None |
ND |
↔ |
↑ |
ND |
Sanli et al., 2015
|
Opium addicted |
Case-control |
n = 115 men/women (46 opium dependent, 69 non-dependent) |
None |
ND |
↔ |
ND |
ND |
Masoomi et al., 2015
|
Opium addicted |
Cross-sectional |
n = 217 men (103 opium addict, 114 non-addict) |
None |
ND |
↔ |
ND |
↔ |
Roohafza et al., 2013
|
Opium addicted |
Cohort |
n = 569 men (99 opium addicts, 470 non-addicts) |
AMI |
↔ |
↔ |
ND |
ND |
Javadi et al., 2014
|
Opium addicted |
Cross-sectional |
n = 304 men/women (152 opium user, 152 non-user) |
AMI |
ND |
↔ |
ND |
↔ |
Bayani et al., 2014
|
Opium (for more Than 6 months) |
Cross-sectional |
n = 97 men/women (48 opium addicts, 49 non-addicts) |
ACS + type 2 diabetes |
↔ |
↔ |
↔ |
Both groups were diabetic |
Najafi and Sheikhvatan, 2012a
|
Opium addicted |
Cross-sectional |
n = 232 (26 opium addicts, 206 non-addicts) |
advanced CAD+ type 2 diabetes |
↓ |
↔ |
↔ |
Both groups were diabetic |
Karam et al., 2004
|
Opium (for at least 1 year) |
Case-control |
n = 98 men/women (49 opium addict, 49 non-addict) |
Type 2 diabetes |
↔ |
↔ |
↑#
|
Both groups were diabetic |
Hosseini et al., 2011
|
Opium (for more than 3 month) |
Cross-sectional |
n =456 men/women (228 opium addict, 228 non-addict) |
Diabetes mellitus |
↓ |
↔ |
ND |
Both groups were diabetic |
Rahimi et al., 2014
|
Opium addicted |
Cross-sectional |
n = 374 men/women (179 opium addict, 195 non-addict) |
Type 2 diabetes |
↓ |
↔ |
↔ |
Both groups were diabetic |
Rezvanfar et al., 2011
|
Opium addicted |
Cross-sectional |
n = 232 men (88 opium user, 144 non-user) |
Type 2 diabetes |
↔ |
↔ |
↓ |
Both groups were diabetic |
Ceriello et al., 1987
|
Heroin (for 2–7 years) Methadone (for 1–3 years) |
Case-control |
n = 45 men (15 heroin addict, 15 methadone treatment, 15 normal) |
None |
↔ |
↔ |
ND |
ND |
Zandomeneghi et al., 1988
|
Heroin (for at least 2 years) |
Case-control |
n = 20 men/women (10 heroin addict, 10 normal) |
None |
↔ |
↔ |
ND |
ND |
Gozashti et al., 2015
|
Opium addicted |
Case-control |
n = 108 men/women (53 opium addict, 55 non-addict) |
None |
↔ |
↑ |
ND |
ND |
Azod et al., 2008
|
Opium addicted |
Case-control |
n =69 men (23 opium addict, 46 non-addict) |
Type 2 diabetes |
↔ |
↓ |
↔ |
Both groups were diabetic |
Afarinesh et al., 2014
|
Opium (for more than 2 years) |
Cross-sectional |
n = 320 men (90 opium dependent, 120 opium withdrawal, 110 healthy) |
None |
ND |
↓ |
ND |
ND |
Shirani et al., 2010
|
Opium addicted |
Cross-sectional |
n = 939 men (opium addicts, and non-addicts) |
CAD |
↓ |
↓ |
↑ |
↓ |
Masoomi et al., 2008
|
Opium addicted |
Cross-sectional |
n = 240 men/women (126 opium addict, 114 non-addict) |
AMI |
ND |
↓ |
ND |
↓ |
Aghadavoudi et al., 2015
|
Opium (for 12.6 ± 7.7 years) |
Cross-sectional |
n = 325 men/women (117 opium addict, 208 non-addict) |
CAD |
↓ |
↓ |
ND |
↓ |
Dehghani et al., 2013
|
Opium addicted |
Cross-sectional |
n = 460 men/women (239 opium addict, 221 non-addict) |
AMI |
ND |
↓ |
ND |
↓ |
Divsalar et al., 2010
|
Opium, Heroin |
Cross-sectional |
n = 112 men (42 opium addict, 35 heroin addict, 35 non-addict) |
None |
↔ |
↓*
|
ND |
ND |
Najafi and Sheikhvatan, 2012b
|
Opium addicted |
Cross-sectional |
n = 268 men/women (38 opium addict, 230 non-addict) |
CAD |
↓ |
ND |
ND |
↓ |
Yousefzadeh et al., 2015
|
Opium addicted |
Cross-sectional |
n = 5332 men/women (811 current opium users, 176 former opium users. 4340 non-user) |
None |
↓ |
ND |
ND |
↑ |
Davoodi et al., 2005
|
Opium addicted |
Cohort |
n = 160 (45 opium-dependent, 115 non-dependent) |
AMI |
ND |
ND |
ND |
↔ |
Najafipour et al., 2015a
|
Opium addicted |
Cross-sectional |
n = 5896 men/women (non-users, occasional users, dependent users) |
normal/T2DM |
↔ |
ND |
↔ |
↔ |